Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V P Masenko

Showing results (151-160 of 190) with videos related to

Pageof 19
Sort By:
Kardiologiia|February 22, 2018
[Head to Head Comparison of Suppression of Tumorogenicity 2 and Copeptin Significance for Prognosis of Patients After Acute Heart Failure Decompensation]O Y Narusov, D E Koshkina, V N Protasov, et al.
Terapevticheskii Arkhiv|November 3, 2006
[Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)]A A Skvortsov, V Iu Mareev, S N Nasonova, et al.
Kardiologiia|September 1, 2011
[Eosinophilic cation protein and development of restenosis of drug covered stents]Z A Gabbasov, S G Kozlov, O S Saburova, et al.
Kardiologiia|November 13, 2019
Head to Head Comparison of Suppression of Tumorogenicity 2 and Copeptin Significance for Prognosis of Patients After Acute Heart Failure DecompensationA A Skvortsov, Vladimir N Protasov, O Yu Narusov, et al.
Terapevticheskii Arkhiv|December 30, 2023
[Effects of sacubitril/valsartan in patients with cancer therapy-related heart failure]M V Vitsenya, A V Potekhina, S V Gavryushina, et al.
Kardiologiia|August 3, 2006
[Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADKO-CHF study]A A Skvortsov, S N Nasonova, A V Sychev, et al.
Terapevticheskii Arkhiv|March 29, 2013
[Effect of bosentan on the clinical status and cellular immunity of patients with idiopathic pulmonary hypertension]T V Martyniuk, K A Zykov, O Iu Antonova, et al.
Kardiologiia|February 2, 2019
V N Protasov, O Yu Narusov, A A Skvortsov, et al.
Terapevticheskii Arkhiv|October 16, 2009
[Influence of chronic cardiac failure severity on the course of comorbid type 2 diabetes mellitus]O Iu Narusov, Iu V Lapina, V Iu Mareev, et al.
Terapevticheskii Arkhiv|November 2, 2006
[Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2]A A Skvortsov, V Iu Mareev, S N Nasonova, et al.
Pageof 19

Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Kardiologiia|February 22, 2018
[Head to Head Comparison of Suppression of Tumorogenicity 2 and Copeptin Significance for Prognosis of Patients After Acute Heart Failure Decompensation]O Y Narusov, D E Koshkina, V N Protasov, et al.
Terapevticheskii Arkhiv|November 3, 2006
[Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)]A A Skvortsov, V Iu Mareev, S N Nasonova, et al.
Kardiologiia|September 1, 2011
[Eosinophilic cation protein and development of restenosis of drug covered stents]Z A Gabbasov, S G Kozlov, O S Saburova, et al.
Kardiologiia|November 13, 2019
Head to Head Comparison of Suppression of Tumorogenicity 2 and Copeptin Significance for Prognosis of Patients After Acute Heart Failure DecompensationA A Skvortsov, Vladimir N Protasov, O Yu Narusov, et al.
Terapevticheskii Arkhiv|December 30, 2023
[Effects of sacubitril/valsartan in patients with cancer therapy-related heart failure]M V Vitsenya, A V Potekhina, S V Gavryushina, et al.
Kardiologiia|August 3, 2006
[Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADKO-CHF study]A A Skvortsov, S N Nasonova, A V Sychev, et al.
Terapevticheskii Arkhiv|March 29, 2013
[Effect of bosentan on the clinical status and cellular immunity of patients with idiopathic pulmonary hypertension]T V Martyniuk, K A Zykov, O Iu Antonova, et al.
Kardiologiia|February 2, 2019
V N Protasov, O Yu Narusov, A A Skvortsov, et al.
Terapevticheskii Arkhiv|October 16, 2009
[Influence of chronic cardiac failure severity on the course of comorbid type 2 diabetes mellitus]O Iu Narusov, Iu V Lapina, V Iu Mareev, et al.
Terapevticheskii Arkhiv|November 2, 2006
[Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2]A A Skvortsov, V Iu Mareev, S N Nasonova, et al.
Pageof 19